Journal of Virology
Published by American Society for Microbiology
ISSN : 0022-538X eISSN : 1098-5514
Abbreviation : J. Virol.
Aims & Scope
The Journal of Virology (JVI) maintains its premier position as a source of broad-based, high-quality, original research concerning viruses.
The journal provides fundamental new information obtained in studies using cross-disciplinary approaches of biochemistry, biophysics, cell biology, genetics, immunology, molecular biology, morphology, physiology, and pathogenesis and immunity.
Sections include: - Spotlights - Commentaries - Minireviews - Structure and Assembly - Genome Replication and Regulation of Viral Gene Expression - Genetic Diversity and Evolution - Virus-Cell Interactions - Cellular Response to Infection - Transformation and Oncogenesis - Gene Delivery - Vaccines and Antiviral Agents - Pathogenesis and Immunity
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3.8 |
2024 | 4.00 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.283 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 330 |
Journal Rank
Year | Value |
---|---|
2024 | 3164 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 7228 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Agricultural and Biological Sciences and Immunology and Microbiology, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
Citation: 3215
Authors: Yushun, Jian, Rachel, Ralph S., Fang
-
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Citation: 2676
Authors: Tom, Romain, Michael, R. J., Minh, Didier, Luigi
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
Citation: 2536
Authors: A, H E, S, T, R, A, M A
-
Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination
Citation: 2359
Authors: Kavita S., Robert C., Ramesh S., Deepak, Smita S., Nicole G., Roxann, Haynes W., Stuart C.
-
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
Citation: 1979
Authors: R A, J T, Y, C A, G, W, C, D D
-
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
Citation: 1524
Authors: P, H, B H, G M, M B
-
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Citation: 1489
Authors: Romain, Thomas, Ronald J., Anatoly, Dulce, Luigi, Didier
-
Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
Citation: 1340
Authors: Patrick C. Y., Susanna K. P., Carol S. F., Candy C. Y., Alan K. L., John H. N., Ru, Jade L. L., Chris C. C., Ming, Bo-Jian, Kwok-Hung, Kwok-Yung
-
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
Citation: 1324
Authors: E. John, Joseph N., Kaja, Robbert, Rafi
-
The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex
Citation: 1225
Authors: Berend Jan, Ruurd, Cornelis A. M., Peter J. M.